Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC38 | GDC-0980 | 2 | 72 | 0.0032 | 3061.0 | 3084.3 | 690.5 | -2.49 | 0.993 | 0.992 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 0.01 | 3051.0 | 3084.3 | 690.5 | -2.0 | 0.990 | 0.989 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 0.032 | 2855.5 | 3084.3 | 690.5 | -1.49 | 0.930 | 0.926 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 0.1 | 2255.3 | 3084.3 | 690.5 | -1.0 | 0.730 | 0.731 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 0.32 | 1610.5 | 3084.3 | 690.5 | -0.495 | 0.480 | 0.522 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 1.0 | 1316.5 | 3084.3 | 690.5 | 0.0 | 0.348 | 0.427 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | GDC-0980 | 2 | 72 | 3.2 | 938.5 | 3084.3 | 690.5 | 0.505 | 0.153 | 0.304 | 2.159 | HCC38 GDC0980 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.001 | 2372.8 | 3009.3 | 690.5 | -3.0 | 0.788 | 0.788 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.0032 | 2817.3 | 3009.3 | 690.5 | -2.49 | 0.939 | 0.936 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.01 | 2084.3 | 3009.3 | 690.5 | -2.0 | 0.682 | 0.693 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.032 | 1659.5 | 3009.3 | 690.5 | -1.49 | 0.511 | 0.551 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.1 | 1213.3 | 3009.3 | 690.5 | -1.0 | 0.304 | 0.403 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 0.32 | 814.8 | 3009.3 | 690.5 | -0.495 | 0.081 | 0.271 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 1.0 | 538.3 | 3009.3 | 690.5 | 0.0 | -0.111 | 0.179 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | Omipalisib | 2 | 72 | 3.2 | 179.0 | 3009.3 | 690.5 | 0.505 | -0.470 | 0.060 | 2.124 | HCC38 GSK458 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.001 | 3129.0 | 3196.0 | 690.5 | -3.0 | 0.981 | 0.979 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.0032 | 3018.0 | 3196.0 | 690.5 | -2.49 | 0.949 | 0.944 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.01 | 3065.8 | 3196.0 | 690.5 | -2.0 | 0.963 | 0.959 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.032 | 3064.3 | 3196.0 | 690.5 | -1.49 | 0.962 | 0.959 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.1 | 3190.3 | 3196.0 | 690.5 | -1.0 | 0.998 | 0.998 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 0.32 | 3080.5 | 3196.0 | 690.5 | -0.495 | 0.967 | 0.964 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 1.0 | 3137.5 | 3196.0 | 690.5 | 0.0 | 0.983 | 0.982 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | KIN001-244 | 2 | 72 | 3.2 | 3015.5 | 3196.0 | 690.5 | 0.505 | 0.948 | 0.944 | 2.210 | HCC38 KIN001-244 0 2 72 |
HCC38 | MK2206 | 2 | 72 | 0.001 | 3051.8 | 3083.8 | 690.5 | -3.0 | 0.990 | 0.990 | 2.159 | HCC38 MK2206 0 2 72 |
HCC38 | MK2206 | 2 | 72 | 0.0032 | 3013.8 | 3083.8 | 690.5 | -2.49 | 0.979 | 0.977 | 2.159 | HCC38 MK2206 0 2 72 |